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Abstract
Introduction Macrophages constitute a heterogeneous population of functionally distinct cells involved in several physi-
ological and pathological processes. They display remarkable plasticity by changing their phenotype and function in response 
to environmental cues representing a spectrum of different functional phenotypes. The so-called M1 and M2 macrophages 
are often considered as representative of pro- and anti-inflammatory ends of such spectrum. Metabolomics approach is a 
powerful tool providing important chemical information about the cellular phenotype of living systems, and the changes in 
their metabolic pathways in response to various perturbations.
Objectives This study aimed to characterise M1 and M2 phenotypes in THP-1 macrophages in order to identify characteristic 
metabolites of each polarisation state.
Methods Herein, untargeted liquid chromatography (LC)–mass spectrometry (MS)-based metabolite profiling was applied 
to characterise the metabolic profile of M1-like and M2-like THP-1 macrophages.
Results The results showed that M1 and M2 macrophages have distinct metabolic profiles. Sphingolipid and pyrimidine 
metabolism was significantly changed in M1 macrophages whereas arginine, proline, alanine, aspartate and glutamate 
metabolism was significantly altered in M2 macrophages.
Conclusion This study represents successful application of LC–MS metabolomics approach to characterise M1 and M2 
macrophages providing functional readouts that show unique metabolic signature for each phenotype. These data could 
contribute to a better understanding of M1 and M2 functional properties and could pave the way for developing new thera-
peutics targeting different immune diseases.
Keywords LC–MS · Macrophage polarisation · THP-1 cell · Metabolite profiling · Metabolic pathway analysis
1 Introduction
Macrophages as effector cells in the immune system, play 
a critical role in innate and adaptive immunity (Martinez 
et al. 2008). They are a heterogeneous population of cells 
with high degree of plasticity and ability to acquire distinct 
functional phenotypes in response to different environmental 
changes and stimuli such as microbial, parasitic, and viral 
antigens, or apoptotic cells (Vogel et al. 2014). Many mac-
rophage populations have now been identified that display a 
broad spectrum of functional phenotypes (Mantovani et al. 
2005). However, two major populations of macrophages with 
distinct functions represent the extreme polarisation states of 
macrophages; pro-inflammatory M1 macrophages and anti-
inflammatory M2 macrophages (Filardy et al. 2010). M1 
macrophages play a crucial role against infectious microbes 
(e.g. bacteria and viruses) and tumour progression whereas 
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M2 macrophages are involved in tissue repair, wound heal-
ing, and in response against parasitic infections (Chanput 
et al. 2013).
Resting or naïve macrophages (M0) can be polarised to 
a pro-inflammatory M1 phenotype by exposure to granu-
locyte macrophage colony-stimulating factor (GM-CSF), 
Th1 cytokines like IFN-γ and TNF-α, and other toll-like 
receptor (TLR) ligands such as bacterial lipopolysaccharide 
(LPS). Polarisation towards anti-inflammatory M2 pheno-
type, on the other hand, is primarily induced via exposure 
to macrophage colony-stimulating factor (M-CSF) and Th2 
cytokines like IL-4 or IL-13 (Martinez et al. 2008; Vogel 
et al. 2014). The balance between pro- and anti-inflamma-
tory macrophage phenotypes plays a central role in mainte-
nance of tissue homeostasis under steady-state conditions 
and after exposure to pathogens and tissue damage (Gu et al. 
2017; Mandal et al. 2011). This is exemplified by various 
autoimmune [e.g. rheumatoid arthritis (Gu et al. 2017), mul-
tiple sclerosis (Bruck et al. 1996) and Crohn’s disease (Smith 
et al. 2009)] and chronic inflammatory diseases [e.g. alco-
holic and non-alcoholic liver diseases (Tilg and Diehl 2000), 
atherosclerosis (Viola and Soehnlein 2015), and diabetes 
(Kraakman et al. 2014)] where dysregulation in macrophage 
function is thought to play a central role (Mandal et al. 
2011; Murphy et al. 2003; Smith et al. 2009). However, the 
molecular events that control M1 and M2 polarisation and 
underpin different functions of pro- and anti-inflammatory 
macrophages are still poorly understood (Lopez-Castejon 
et al. 2011).
Characterisation of macrophage polarisation has been 
studied widely. Chanput et al. recently reported characteri-
sation of THP-1 macrophages for both M1 and M2 pheno-
types using expression of chemokines and surface marker 
receptors. This study demonstrated that chemokines and 
surface receptors could be inappropriate markers for char-
acterising different macrophage polarising states particu-
larly for M2 subset which was less sharply defined because 
chemokines are affected by secondary cell–cell signals that 
are crucial to drive M2 polarisation (Chanput et al. 2013). 
In another study, Lopez-Castejon et al. have shown specific 
gene expression profile which controls M1 and M2 mac-
rophage phenotypes (Lopez-Castejon et al. 2011). Also, 
Sierra-Filardi et  al. demonstrated a characteristic high 
expression of C–C chemokine receptor type 2 (CCR2) and 
C–C chemokine ligand 2 (CCL2) genes in M1 and M2 mac-
rophages, respectively (Sierra-Filardi et al. 2014). However, 
gene expression profiling does not account for differences 
in functional phenotype and cannot reveal the complexity 
of biological samples (Kosmides et al. 2013). Furthermore, 
a great overlap in the expression of surface markers has 
been reported between different macrophage subsets and 
more importantly deciphering function based on surface 
phenotype is not always possible (Geissmann et al. 2010). 
Therefore, there is a need for more functional biological 
readouts that not only allow better classification of different 
macrophage subsets but also provide better insight into the 
molecular mechanisms that underpin distinct functional and 
phenotypical subsets. Given the mounting evidence high-
lighting a strong correlation between the metabolic state 
and the functional phenotype of macrophages, metabolite 
profiling could prove as a powerful tool for better classifi-
cation and understanding of different macrophage pheno-
types (Galván-Peña and O’Neill 2014; Rath et al. 2014). For 
examples, M1 macrophages have been characterised by high 
levels of glycolysis and flux through the pentose phosphate 
pathway (PPP), and an increase in particular tricarboxylic 
cycle (TCA cycle) metabolites such as citrate, succinate and 
itaconate. Moreover, M1 macrophages have increased fatty 
acids synthesis (Galván-Peña and O’Neill 2014; Jha et al. 
2015). On the other hand, M2 macrophages adopt oxidative 
phosphorylation and fatty acids oxidation (Covarrubias et al. 
2015). These key metabolic differences between M1 and M2 
macrophages are widely accepted. However, the metabolic 
mechanisms that underpin the orchestrating of their profiles 
remain not well understood. Also, M1 macrophages are dis-
tinctive with the expression of nitric oxide synthase (iNOS) 
that facilitates the production of NO, which has anti-micro-
bial activity and cytotoxicity whereas M2 macrophages 
express arginase-1 instead that is required in the production 
of polyamines which are necessary for cell proliferation, col-
lagen synthesis and tissue remodelling (Covarrubias et al. 
2015; Orihuela et al. 2016).
Liquid chromatography (LC)–mass spectrometry (MS)-
based metabolomics approach is a powerful tool for quan-
tifying metabolites as well as for identifying known and 
unknown compounds in biological samples (Surrati et al. 
2016). Therefore, this technique has been used widely for 
disease diagnostic biomarker discovery (Jansson et al. 2009) 
as well as evaluation of drug toxicity (Sun et al. 2009). In 
addition, LC–MS-based approach has been employed 
to investigate the function of immune cells and immune 
responses by monitoring level changes of signalling mol-
ecules. Tannahill et al. have successfully revealed succinate 
as an inflammatory signal in lipopolysaccharide (LPS)-acti-
vated bone marrow-derived macrophages (BMDMs) using 
LC–MS metabolomics approach (Tannahill et al. 2013a). 
Also, Hollenbaugh et al. have demonstrated that LC–MS/
MS metabolomics was an effective approach to monitor vari-
ous metabolic alterations in HIV-1 infected primary human 
CD4 + T cells and a macrophage model system (Hollen-
baugh et al. 2011). Moreover, LC–MS metabolomics has 
been effectively used to monitor LPS-induced changes in 
amino acid metabolism of macrophage-like cell line (RAW 
264.7) and to identify relevant pathways (Suh et al. 2012). 
In the context of macrophages polarisation, a recent study 
has used integrated transcriptomics and LC–MS-based 
Metabolic characterisation of THP-1 macrophage polarisation using LC–MS-based metabolite…
1 3
Page 3 of 14    33 
metabolomics to investigate the polarisation and the dis-
tinct metabolic profiles of M1 and M2 macrophages in mice. 
They demonstrated that M2 macrophages activate glutamine 
catabolism and UDP-N-acetylglucosamine (UDP-GlcNAc)-
related modules. On the other hand, they identified interrup-
tion in the TCA cycle between isocitrate and α-ketoglutarate 
(OXPHOS) in M1 macrophages (Jha et al. 2015). Using 
LC–MS metabolomics, Mills et al. have shown that itaco-
nate is an anti-inflammatory metabolites which has impor-
tant role in regulation of macrophage functions (Mills et al. 
2018). However, Rattigan et al. demonstrated a complex role 
of itaconate as an inflammatory and anti-inflammatory key 
metabolite (Rattigan et al. 2018). Moreover, another metabo-
lomics study of macrophages has identified succinate as a 
participant in innate immune signalling in response to LPS 
(M1 macrophages) where its increase results from impaired 
TCA cycle and leads to boost the production of the inflam-
matory cytokine, IL-1β during inflammation (Tannahill et al. 
2013b). Also, Freemerman et al. demonstrated that driving 
glucose uptake and metabolism through glucose transport-
ers in macrophages induces a proinflammatory response and 
the metabolomics analysis revealed increase in glycolysis, 
PPP, purine and pyrimidine metabolism (Freemerman et al. 
2014). However, metabolic signature of human macrophage 
polarisation states has not been investigated yet.
In this study, untargeted LC–MS-based metabolite profil-
ing was employed to characterise M1 and M2 phenotypes in 
THP-1 macrophages in order to identify the key characteris-
tic metabolites of each polarisation state in these cells. Our 
data clearly showed distinct metabolic signature and asso-
ciated changes of relevant metabolites in M1 and M2 mac-
rophages which could not only provide better understanding 
of the functional properties of different macrophage subsets 
but also pave the way for identifying new key characteristic 
metabolites and potentially therapeutic targets in different 
inflammatory diseases.
2  Materials and methods
2.1  Materials
THP-1 cell line was purchased from ATCC, USA. RPMI 
1640 medium, phosphate buffered saline (PBS) and E. coli 
lipopolysaccharide were purchased from Sigma-Aldrich, 
UK. GM-CSF, M-CSF and IL-4 were purchased from Milte-
nyi Biotec, Germany. IFN-γ was purchased from R&D Sys-
tems, USA. Methanol and acetonitrile were purchased from 
Fisher Scientific, UK. All solvents were LC–MS grade.
2.2  Methods
2.2.1  Cell culture
Human THP-1 cells were cultured and differentiated as pre-
viously described in (Chanput et al. 2013). Briefly, THP-1 
cells were grown in T75 tissue culture flasks using RPMI 
1640 supplemented with 10% heat-inactivated fetal bovine 
serum (FBS), 1% l-glutamine, and 1% penicillin–streptomy-
cin. Cells were then incubated at 37 °C and 5%  CO2.
2.2.2  Differentiation and polarisation of THP‑1 cells
THP-1 cells were differentiated into naïve macrophages-
like state (M0-like) by treating with phorbol-12-myristate-
13-acetate (PMA). Six million cells were seeded per flask 
(T25 tissue culture flask), and then the cells were treated 
with PMA containing media with a final concentration of 
50 ng/ml of PMA and incubated for 6 h. After the incuba-
tion period, the cells were further treated with either 50 ng/
ml GM-CSF, 100 ng/ml LPS and 20 ng/ml IFN-γ or 50 ng/
ml M-CSF and 20 ng/ml IL-4 for up to 72 h to generate 
M1 or M2 polarised cells, respectively (Caras et al. 2011). 
This polarisation protocol was adapted from previous studies 
(Caras et al. 2011; Rostam et al. 2017) and the cell pheno-
types were confirmed by conventional assays (Supplemen-
tary 1). Cells treated with PMA only were used as controls 
(M0). Six replicates for each condition were prepared.
2.2.3  Sample preparation and metabolite extraction
After incubated for 72 h, the media containing PMA and 
polarising agents were removed. The cells were then washed 
once with pre-warmed PBS (37 °C) and 500 µl of pre-cooled 
methanol at − 48 °C was used for metabolism quenching 
and metabolite extraction. The cells were harvested using 
a plastic scraper whilst being kept on ice and the extracts 
were transferred into pre-cooled fresh tubes (4 °C). The cell 
extract was vortexed for 1 h and centrifuged at 16,100×g for 
10 min at 4 °C. After the centrifugation, the supernatants 
were transferred into pre-cooled fresh tubes (4 °C) and they 
were then dried under vacuum and reconstituted in 70 µl 
of methanol. The samples were stored at − 80 °C prior to 
LC–MS analysis. To assess the instrument performance, a 
quality control (QC) sample was prepared by mixing equal 
volume of each sample.
2.2.4  Analytical methodologies
LC–MS-based metabolite profiling was performed on an 
Accela system coupled to an Exactive MS (Thermo Fisher 
Scientific, Hemel Hempstead, UK) operating with electro-
spray ionisation (ESI) running in the negative (ESI−) and 
 A. Abuawad et al.
1 3
  33  Page 4 of 14
positive (ESI+) modes as previously described in (Kim 
et al. 2015). Briefly, the spray voltage was 4500 V (ESI+) 
and 3500 V (ESI−), capillary voltage was 40 V (ESI+) and 
30 V (ESI−), tube lens voltage was 70 V for the both modes 
and skimmer voltage was 20 V (ESI+) and 18 V (ESI−). 
The temperature for capillary and probe was maintained at 
275 °C and 150 °C, respectively. Chromatographic separa-
tion was carried out using ZIC-pHILIC (4.6 × 150 mm and 
5 μm particle size, Merck Sequant). The mobile phase com-
posed of 20 mM ammonium carbonate in water (solvent A) 
and 100% acetonitrile (solvent B). Metabolites were sepa-
rated according to a linear gradient as following: 0–15 min 
(20% A), 15–17 min (95% A), and 17–24 min (20% A) at 
300 µl/min flow rate. The injection volume of 10 µl and the 
column was kept at 45 °C.
2.2.5  Data processing and metabolites identification
To process raw data obtained from LC–MS, XCMS and 
mzMatch were used for untargeted peak-picking and peak 
matching, respectively (Scheltema et al. 2011; Tautenhahn 
et al. 2008). IDEOM was employed for putative metabolite 
identification and noise filtering with default parameters 
(Creek et al. 2012). Briefly, retention time (RT) for identifi-
cation of authentic standards was 5%, RT for identification 
for calculated RT was 50%, mass accuracy for mass iden-
tification was 3 ppm. Metabolites were identified with four 
levels of confidence; level 1 (L1) identification was based 
on matching the accurate masses, MS/MS fragmentation 
and retention times of the detected metabolite peaks with 
those of 250 authentic standards which were co-analysed 
with the samples under identical experimental conditions, 
level 2 (L2) identification was based on matching the accu-
rate masses and retention times (two orthogonal data) of 
the detected metabolite peaks with those of the authentic 
standards, level 3 (L3) identification was carried out when 
the predicted retention times were employed due to the lack 
of standards and level 4 (L4) identification was based on 
unambiguously assigned molecular formulas but insufficient 
evidence exists to propose possible structures. The identifi-
cation criteria were according to the metabolomics standards 
initiative and scale by (Schymanski et al. 2014; Sumner et al. 
2014, 2007).
Pre-processed data were analysed by performing mul-
tivariate and univariate analysis. Orthogonal partial least 
squares-discriminant analysis (OPLS-DA) was carried 
out by SIMCA-P v13.0.2 (Umetrics, Umea, Sweden) as a 
supervised multivariate model. This multivariate analysis 
was used as the first step for visualising data with sample 
classes and evaluating the metabolome changes in M0, M1, 
and M2 groups. The key mass ions representing potential 
characteristic metabolites were determined based on variable 
importance in projection (VIP) values obtained from two-
way orthogonal comparisons. Mass ions with VIP values 
greater than one were considered as discriminant key charac-
teristic metabolites. Univariate analysis was also performed 
in parallel to multivariate analysis to identify significant 
mass ions. T-test with false discovery rate (FDR) correc-
tion was performed using MetaboAnalyst (Leon et al. 2013) 
to determine the significantly changed mass ions between 
unpolarised THP-1 macrophages (M0) and polarised groups 
(M1 and M2). MetaboAnalayst and Kyoto Encyclopedia of 
Genes and Genomes (KEGG) database were used to analyse 
and visualise the affected pathway.
3  Results and discussion
3.1  Macrophages characterisation using surface 
markers and cytokine profile
As previously mentioned, macrophages adopt a range of 
phenotypes in response to different micro-environmental 
stimuli. To generate M1 cells, naïve THP-1 macrophages 
were treated with GM-CSF, LPS (a potent endotoxin) and a 
Th1 cytokine, IFN-γ, while M2 cells were generated using 
M-CSF and a Th2 cytokine, IL4. These biomolecules have 
been shown to drive macrophage polarisation down the 
pro-inflammatory or anti-inflammatory path, respectively 
(Gordon and Plüddemann 2017; Mantovani et al. 2004). To 
confirm the efficiency of the polarisation approach used in 
this study, the morphology, surface phenotypic markers and 
cytokine profile of cells in response to different cytokine 
treatments were analysed. For the visualisation of cell 
cytoskeleton, different macrophage subsets were stained 
with fluorescently labelled phalloidin. M1 cells showed a 
less rounded and elongated morphology while M2 cells 
appeared rounded and stretched, displaying a ‘fried egg 
like’ morphology; M0 cells had rounded but less stretched 
cells (Supplementary 1 Fig. 1). Results obtained were in 
line with existing morphological data for different mac-
rophage subsets (Rostam et al. 2016; Toniolo et al. 2015). 
To find out the surface phenotype of each cell population, 
immunofluorescence staining for calprotectin and mannose 
receptor (Huang et al.), which have been associated with 
M1 and M2 cells, respectively (Rostam et al. 2016), was 
carried out. As shown in Supplementary 1 Fig. 2, M1 cells 
expressed higher levels of calprotectin and lower levels of 
MR compared to M2 and M0 cells. On the other hand, M2 
cells expressed the highest level of MR with no calprotec-
tin expression. Additionally, the levels of cytokines in the 
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supernatants collected from the macrophage subsets were 
analysed by enzyme-linked immunosorbent assay (Toniolo 
et al. 2015). M1 cells expressed significantly higher levels 
of pro-inflammatory cytokines, TNF-α and IL-1β compared 
to M2 and M0 macrophages (Supplementary 1 Fig. 3). As 
anticipated, our polarisation approach induced distinct M1 
and M2 macrophages, characterised by increased expres-
sion of pro-inflammatory (calprotectin, TNF- α, IL-1 β) or 
anti-inflammatory markers (Huang et al. 2014), respectively.
3.1.1  Untargeted metabolomics analysis of THP‑1 
polarised macrophages
In order to explore the changes in the metabolic profile of 
THP-1 macrophages upon polarisation to M1 and M2 sub-
sets and identify potential key characteristic metabolites for 
each macrophages polarisation state, the extracted intracel-
lular metabolites from M0 group (unpolarised) and polarised 
groups were analysed using a LC–MS-based technique. 5474 
features were detected in positive and negative modes with 
total of 644 metabolites were identified putatively (Supple-
mentary 2). Figure 1 shows the chemical composition of 
THP-1 macrophages with the biological classifications of the 
identified metabolites. The metabolome was mainly consti-
tuted of glycerophospholipids (20%) and amino acids (17%), 
respectively followed by fatty acyls (7%), other lipids (6%), 
Fig. 1  Functional categories of the intracellular metabolites produced 
by THP-1 macrophages. In total, 644 metabolites were putatively 
identified in THP-1 macrophage extracts using LC–MS-based metab-
olite profiling
Fig. 2  OPLS-DA scores plots of macrophage extracts after polari-
sation toward M1 and M2 states and their corresponding unpolar-
ised (M0) controls. a M1 and M2 macrophage samples and their 
respective unpolarised controls  (R2 = 0.647 and  Q2 = 0.847). b Two-
way orthogonal comparison between M0 and M1  (R2 = 0.664 and 
 Q2 = 0.899). c Two-way orthogonal comparison between M0 and M2 
 (R2 = 0.711 and  Q2 = 0.838). M0 (yellow circles), M1 (blue squares), 
and M2 (purple triangles). n = 6
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carbohydrates (5%), nucleotides (3%), sphingolipids (3%), 
co-factors and vitamins (2%), and energy metabolites (1%).
3.1.2  Feature selection and identification of potential 
biomarker metabolites
In order to reveal the key metabolites representing potential 
key characteristic metabolites for the two polarisation states 
of macrophages, the pre-processed data were imported to 
SIMCA-P to perform multivariate analysis. OPLS-DA was 
performed to distinguish M0, M1 and M2 groups. OPLS-
DA scores plot showed tight clustering of the six replicates 
within each group and clear separation between the three 
different groups (M0, M1, and M2 macrophages) with  R2 
and  Q2 values of 0.647 and 0.847, respectively (Fig. 2). Six 
replicates were deemed to be valid for this type of cell line-
based studies (Alazzo et al. 2019; Surrati et al. 2016). This 
separation indicated a distinctive metabolic signature of M1, 
M2 and M0 macrophages.
Two-way comparison illustrated in Fig. 2b and c was 
performed to determine the mass ions which contributed 
to the separation between M0 and M1 or M2 macrophages 
based on their VIP values. The mass ions with VIP values 
greater than one were considered as potential key mass ions. 
OPLS-DA scores plot showed a clear separation between M0 
and M1groups (Fig. 2b) with  R2 and  Q2 values of 0.664 and 
0.899, respectively, demonstrating an acceptable OPLS-DA 
model (Eriksson et al. 2006). In parallel, univariate t-test 
with FDR correction was performed to identify significantly 
changed mass ions (FDR < 0.05) in M1 compared to the cor-
responding control (M0). Combination of multivariate and 
univariate analysis revealed 90 significantly changed metab-
olites in M1 macrophages (Supplementary 3). Similarly, 
in Fig. 2c, OPLS-DA scores plot showed clear separation 
between M0 and M2 macrophages with  Q2 and  R2 values of 
0.838 and 0.711, respectively.
Again, univariate t-test with FDR correction was per-
formed in parallel to identify significant mass ions changed 
in M2 group compared to the corresponding control (M0), 
revealing 49 significantly changed metabolites in M2 mac-
rophages (Supplementary 4). Table 1 shows the top twenty 
significant metabolites with higher fold changes (1.97 to 
15.44) in M1 and M2.
3.2  Pathway analysis
For further investigation to identify the metabolic pathways 
significantly altered by M1 and M2 polarisation states, a 
summary of pathway analysis is illustrated in Fig. 3a and 
b. Figure 3a and b show that glycerophospholipids (GLs) 
metabolism was significantly changed in M1 as well as M2. 
Glycerophospholipids constitute the main components of 
the cell membrane (Strickland et al. 1963). They mainly 
include phosphatidylcholines (PC), phosphatidylethano-
lamines (PE), phosphatidylserines (Strickland et al. 1963), 
phosphatidylinositols (PI) and phosphatidylglycerols (PG). 
The level of GLs in polarised macrophages (M1 and M2) 
was significantly increased and this results clearly from the 
increased levels of PC, PS and PE (Supplementary 3 and 4). 
Figure 4a–c show different GLs such as PC (14:2/16:0), PS 
(18:0/20:4), and PE (18:1/22:6) that significantly increased 
in M1 or M2. This agrees with recent research where Zhang 
et al. detected increase in the composition of medium- and 
long-chain polyunsaturated GLs, such as PS, PC, PE, and 
PI upon macrophages polarisation into M1 and M2 pheno-
types, compared to M0 (Zhang et al. 2017). Generally, lipid 
metabolism contributes to the pro- or anti-inflammatory 
functions of macrophages by meeting energetic require-
ments and modulating membrane fluidity (Mukundan et al. 
2009). However, GLs are also involved in multiple biologi-
cal processes, such as inflammation and cell differentiation 
(Masoodi et al. 2015).
Sphingolipids and pyrimidine metabolisms were sig-
nificantly altered in M1 macrophages as shown in Fig. 3a. 
Sphingolipids constitute a large class of bioactive and struc-
tural lipids representing the main lipid component of the 
eukaryotic plasma membrane. Sphingolipids are metabo-
lised by a family of enzymes that regulate their metabolic 
interconnected network (Kihara et al. 2007). In recent years, 
different aspects of sphingolipids function have been investi-
gated, including their role in inflammation (El Alwani et al. 
2006), signalling pathways and metabolism (Zheng et al. 
2006). The key metabolite in sphingolipids metabolism is 
ceramide which is generated either through another sphin-
golipid metabolism or in a de novo pathway at the endo-
plasmic reticulum (ER) (Siow and Wattenberg 2014). This 
obvious alteration in sphingolipid pathway is attributed to 
significant increase in the levels of some of sphingolipids 
and ceramides which could be considered as potential key 
characteristic metabolites for M1 macrophages. The levels 
of sphingolipids such as, ceramide (d18:1/24:0), ceramide 
(d18:1/22:0) and ceramide (d18:1/16:0) increased signifi-
cantly in M1 macrophages as shown in Fig. 4a–c, respec-
tively. It was demonstrated that stimulation of macrophages 
(RAW264.7) with LPS or another TLR-4 agonist elevates 
ceramide levels by multiple mechanisms, including de novo 
synthesis pathway (Sims et al. 2010b). Similarly, Cuschieri 
et al. reported that formation of ceramide could be involved 
in the gathering of Toll-like receptor (TLR) as a response 
to bacterial antigens such as lipopolysaccharide (LPS) 
(Cuschieri et al. 2007). Gathering and activation of TLR 4 in 
response to LPS drives a switch from oxidative phosphoryla-
tion into glycolysis which increases the reactive oxygen spe-
cies (ROS) production (Kelly and O’Neill 2015), although 
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our data showed no significant changes in the glycolysis 
intermediates. ROS is important for killing bacterial cells, 
which is significant function of M1 macrophages (Chanput 
et al. 2013). Others showed an increase in ceramide levels 
and inducing TLR4 mediated response in both leukaemia 
and epithelial cells in response to microbial ligands such 
as LPS (Cuschieri et al. 2006). Furthermore, a recent lipo-
domic study demonstrated an increase in the total cellular 
Fig. 3  Summary of pathway analysis by MetaboAnalyst. The top-
pathways are ranked by the gamma-adjusted p values for permuta-
tion per pathway (y-axis) and the total number of hits per pathway 
(x-axis). The colour graduated from white to yellow, orange and red 
as the values of both x and y increase. a Metabolic pathways signifi-
cantly changed in M1 macrophages. b Metabolic pathways signifi-
cantly changed in M2 macrophages
Fig. 4  GLs and sphingolipids that significantly affected upon polari-
sation. a PC (14:2/16:0), b PS (18:0/20:4), and c PE (18:1/22:6) rep-
resent some GLs increased significantly in M1 or M2 macrophages 
compared to M0 macrophages. d Ceramide (d18:1/24:0), e Ceramide 
(d18:1/22:0) and f Ceramide (d18:1/16:0) as potential key character-
istic metabolites of M1 macrophages and their significant increase 
compared to M0 and M2 macrophages
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sphingolipids after TLR4 activation of murine macrophages 
(RAW 264.7 cells). Therefore, our results are in line with 
previous studies showing increase in ceramide production 
in pro-inflammatory macrophages. However, the mechanism 
responsible for increase in the synthesis of sphingolipids in 
TLR4-stimulated cells is still unknown (Sims et al. 2010a).
However, while the HILIC-MS-based approach employed 
in this study allowed the screening of a wide range of lipids 
and was thus ideally suited to initial determination of sig-
nificant changes in lipid metabolism caused by macrophage 
polarisation states, the method was not suitable for separa-
tion and robust identification of individual lipids. Therefore, 
more detailed lipidomic approach using suitable separation 
techniques and structural confirmation based on fragmen-
tation information will be another prospective approach 
revealing the lipid signature of M1 and M2 macrophages. 
This will be a complementary aspect with existing metab-
olomics data providing a clearer picture of macrophage 
responses.
Pyrimidine metabolism was another significantly per-
turbed pathway in M1 macrophages as can be seen in 
Fig. 3a. Pyrimidine is found in the form of nucleic acid and 
vitamins in living systems. It represents the basic nucleus in 
RNA and DNA. Therefore, it has been found to be involved 
in several biological activities (Bhat and Kumar 2017). Bio-
logically, pyrimidines are considered as a very important 
class and represent the most abundant member of diazine 
family with uracil and thymine (Sharma et al. 2014). Numer-
ous studies in the literature showed a broad range of thera-
peutic activity of pyrimidine nucleus-containing compounds 
such as antibacterial (Nargund et al. 1992) and antitubercular 
(Sawant and Kawade, 2011). Our results showed significant 
increase in the levels of cytidine, a pyrimidine that can be 
used as a potential new key characteristic metabolite for M1 
macrophages (Fig. 5). These metabolites are involved in 
pyrimidine metabolism (KEGG map 00240). Increase in the 
levels of pyrimidines could result from pentose phosphate 
pathway (PPP) (KEGG map 00030) which is well known to 
Fig. 5  Significant metabolic pathways upon polarisation of THP-1 
macrophages toward M1 and M2 states with bar graphs of key metab-
olites that significantly changed, the other metabolites either identi-
fied with no significant change (pyruvate, citrate, G6P, glutamate, 
ornithine and arginine) or unidentified. Metabolic enzymes are as 
follows; 1: pyruvate dehydrogenase, 2: pyruvate carboxylase, 3: glu-
tamate-aspartate aminotransferase, 4: l-aspartate N-acetyltransferase, 
5: N-acetylglutamate synthetase, 6: formiminoglutamase, 7: imida-
zolonepropionase, 8: tryptophan 5-monooxygenase, 9: arylalkylamine 
N-acetyltransferase, 10: ornithine aminotransferase, 11: arginase-1, 
12: ribosylpyrimidine nucleosidase, 13: pyrimidine-nucleoside 
phosphorylase. G6P: glucose 6-phosphate, PRPP: 5-phosphoribosyl 
1-pyrophosphate, F6P: fructose 6-phosphate. The bar charts show 
the peak intensity (y-axis) of corresponding metabolites, from the top 
to the bottom and left to right (cytidine, N-Ac-l-Asp, N-Ac-l-Glu, 
4-imidazolone-5-propanoate, 5-hydroxy-tryptophan and N-acetylsero-
tonine). M0 in yellow, M1 in blue and M2 in purple
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be induced in M1 macrophages, and it enhances the produc-
tion of pyrimidines as previously reported (Galván-Peña and 
O’Neill 2014). Nevertheless, metabolites involved in PPP 
showed no significant change in our results unexpectedly. 
Intensive research has been carried out to investigate activ-
ity of pyrimidines in inflammation. Bonnert et al. reported 
remarkable activity of pyrimidine derivatives against inflam-
mation and immune disorders such as rheumatoid arthritis, 
atherosclerosis, and Crohn’s disease (Bonnert et al. 2003). 
Furthermore, Nargund et al. showed potent antibacterial 
activity of pyrimidine derivatives against various gram-
negative and gram-positive bacteria (Nargund et al. 1992). 
Collectively, these studies have revealed the activity of 
pyrimidines in inflammation and bacterial attack which is 
a pivotal role for M1 macrophages (Chanput et al. 2013). 
Also, purines along with pyrimidines are key components 
in the production of RNA and DNA. They have crucial role 
in energy system (e.g., ATP) (Jankowski et al. 2005) and 
enhanced PPP flux increases the production of purines as 
well as pyrimidines (Bedard and Krause 2007). Our data 
demonstrated a significant increase in the purines; hypox-
anthine and inosine (Supplementary 3). In agreement with 
our results, hypoxanthine was reported to be increased in 
the presence of LPS (Rattigan et al. 2018). Pyrimidines and 
purines can be used for the activated cell biosynthesis and 
provide NADPH which is the substrate for NADPH oxi-
dase in order to produce reactive oxygen species (Bedard 
and Krause 2007) that act as a bacterial killing mechanism 
(West et al. 2011) representing the main function of M1 
macrophages. Furthermore, a previous study showed that the 
purines analogue (6-N-hydroxylaminopurine) has antibacte-
rial and antiviral activity (Krajewski et al. 2017).
Figure 5 shows two metabolites with significant increase 
that could also be considered as potential key characteristic 
metabolites for M1 macrophages; 5-hydroxy-l-tryptophan 
and N-acetylserotonin which are intermediates in tryptophan 
metabolism (KEGG map 00380). 5-hydroxy-l-tryptophan 
are generated as a result of tryptophan breakdown by trypto-
phan hydroxylase (KEGG R01814) followed by the reaction 
KEGG R02701 producing serotonin. N-Acetylserotonin is 
produced from serotonin by the reaction KEGG R02911. 
The precursor tryptophan is an amino acid required for meta-
bolic functions and protein synthesis. It cannot be synthe-
sised in the body; therefore, it must be supplied in the form 
of proteins. Although many studies have focused on the role 
of tryptophan metabolism in the last decades, its role and the 
role of intermediates in the immune system are not yet fully 
understood. However, tryptophan metabolism and inflam-
matory responses are thought to be associated with several 
diseases and pathological conditions (Moffett and Nam-
boodiri 2003). For instance, Tarique et al. revealed a role 
of 5-hydroxy tryptophan in innate immunity as it attracts 
mast cells to the inflammation site (Kushnir-Sukhov et al. 
2006). Moreover, Nakumura et al. showed that 5-hydroxy 
tryptophan enhanced phagocytosis in murine macrophages 
(Nakamura et al. 2008), a key property by which M1 mac-
rophages eliminate foreign particles (Tarique et al. 2015).
On the other hand, arginine, proline metabolism, and 
alanine, aspartate and glutamate metabolism were all sig-
nificantly altered in M2 macrophages (Fig. 3b). l-Arginine 
is considered as a non-essential amino acid at the whole 
organism level, but it is important to be supplemented in 
certain diseases (Bansal and Ochoa 2003). It is believed that 
mammalian arginine metabolism and its cellular regulation 
is a complex process (Morris 2006). l-Arginine is produced 
from de novo arginine production or cellular protein break-
down. Many amino acids are involved in the biosynthesis of 
arginine such as l-citrulline, l-ornithine and l-glutamine. 
Furthermore, l-arginine represents a precursor for the syn-
thesis of urea, nitric oxide, l-glutamate, polyamines, l-pro-
line, and creatine (Wu and Morris 1998). Corraliza et al. pre-
viously demonstrated a key aspect of arginine metabolism 
which showed that different enzymes involved in arginine 
metabolism are promoted in macrophages based on their 
polarisation state (M1 or M2). Arginine in macrophages is 
catabolised by either iNOS in M1 macrophages producing 
NO and citrulline or arginase-1 in M2 macrophages pro-
ducing l-ornithine, polyamines (putrescine, spermidine and 
spermine), and urea, which are involved critically in wound 
healing and tissue repair function of M2 macrophages (Cor-
raliza et al. 1995). In agreement with this statement our 
results showed significant increase in l-citrulline (Supple-
mentary 3). This has been proved by Sugimoto et al. dem-
onstrating excessive increase in l-citrulline in LPS-activated 
macrophages (Sugimoto et al. 2012). Figure 5 shows three of 
potential key characteristic metabolites for M2 macrophages; 
N-acetyl-l-glutamate (N-Ac-l-Glu), N-acetyl-l-aspartate 
(N-Ac-l-Asp), and 4-imidazolone-5-propanoate that signifi-
cantly increased in these cells. N-acetyl-l-glutamate is pro-
duced by a reaction of acetyl-CoA with l-glutamate (KEGG 
R00259). Acetyl-CoA is generated from β-oxidation of fatty 
acids which was proved to be utilised in M2 macrophages 
(Huang et al. 2014). However, l-glutamate is interconverted 
from l-ornithine by the enzyme ornithine aminotransferase 
(KEGG R00667). As aforementioned, l-ornithine is known 
to be produced in M2 macrophages from l-arginine via argi-
nase-1, and is represented as a substrate for the enzyme orni-
thine decarboxylase in the synthesis of polyamines induced 
in M2 macrophages (Rath et al. 2014). The other signifi-
cantly altered pathway in M2 macrophages was alanine, 
aspartate, and glutamate metabolism, which is connected to 
TCA cycle. No significant change was shown in TCA cycle 
intermediates, which could indicate intact and function-
ing TCA cycle tightly linked to fully functioning oxidative 
phosphorylation (OXPHOS) of mitochondria. OXPHOS was 
reported as a hallmark of M2 macrophages (Galván-Peña 
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and O’Neill 2014). Therefore, l-aspartate could be driven 
from TCA cycle by oxaloacetate (KEGG R00355) and con-
sequently to be consumed in a reaction with acetyl-CoA 
to produce N-Ac-l-Asp by l-aspartate N-acetyltransferase 
(KEGG R487) which could explain the decrease in the level 
of l-aspartate and increase in the level of N-acetyl-l-aspar-
tate. 4-Imidazolone-5-propanoate could represent another 
source for glutamate (KEGG R02288 and R02285) which, 
in addition to producing N-Ac-l-Glu, glutamate could feed 
into TCA cycle by being converted to α-ketoglutarte by glu-
tamate dehydrogenase.
Surprisingly, glycolysis metabolic pathway, PPP and 
OXPHOS showed no significant difference in their inter-
mediates although many of these metabolites were identi-
fied (Supplementary 4). These metabolic pathways represent 
hallmarks for M1 (glycolysis and PPP) and M2 macrophages 
(OXPHOS which connected to TCA cycle) as discussed ear-
lier. These results can be owed to different reasons. Firstly, 
macrophages heterogenicity and diversity enable the genera-
tion of infinite number of phenotypes with different profiles 
under the impact of varying stimuli (Martinez et al. 2013; 
Weigert et al. 2018). Our protocol of polarisation used multi 
stimuli for M1 and M2 macrophages which were LPS, GM-
CSF and IFN-γ for M1 macrophages and IL-4 and M-CSF 
for M2 macrophages. However, most of the studies used 
LPS or/and IFN-γ for M1 and IL-4 for M2 macrophages. 
GM-CSF and M-CSF can give rise to pro-inflammatory 
and anti-inflammatory macrophages, respectively, and so it 
is expected that they impact the metabolic profile of mac-
rophage phenotypes (Akagawa 2002; Rattigan et al. 2018). 
It was already reported that using LPS alone, IFN-γ alone 
or both of them together gives rise to different metabolic 
response of macrophages (Rattigan et al. 2018). Therefore, 
metabolic responses to different stimuli can be sufficiently 
different, contradictory and seriously complex. This in turn 
suggests that the studies with single or limited number of 
stimuli do not reflect the complexity of the picture in vivo 
(Rattigan et al. 2018). Secondly, and most importantly, most 
of the previous studies discussed the metabolic signature 
of M1 and M2 in mice macrophages, either primary or cell 
line stimulated with in vitro stimuli whereas our experiment 
was conducted using human cell line (THP-1 cells). In fact, 
macrophages from different species, residing different tis-
sues or arising from different progenitors may show different 
biological and metabolic signature, even to defined stimuli 
(Artyomov et al. 2016; Weigert et al. 2018). This could high-
light the need to focus on primary human macrophages in 
the future studies to acquire the more accurate reflection of 
the biology and signature of macrophages however the large 
number of cells required for conventional metabolomics 
studies and access to human tissue limit the feasibility of 
such studies.
4  Conclusion
In this study, LC–MS-based metabolite profiling was used 
successfully to characterise M0, M1 and M2 macrophages. 
Furthermore, uni- and multivariate analysis demonstrated 
that this technique is sensitive enough to detect subtle 
changes in a wide range of metabolites upon polarisation of 
macrophages and identify the distinct metabolic signature 
of M1 and M2 phenotypes. Various metabolic pathways 
were significantly affected in these macrophage pheno-
types. Given the significant number of diseases associated 
with each phenotype such as chronic inflammatory diseases 
or cancer progression, the identified key metabolites will 
improve the understanding of underlying mechanisms in 
macrophages polarisation. Moreover, this data provides new 
insight for the rational design of novel immune modulatory 
strategies such as targeting specific pathways associated 
with different macrophage subsets in inflammatory diseases. 
Future studies should take into consideration different type 
of stimuli for macrophage polarisation to resemble the multi-
ple stimuli present in vivo to account for the diverse range of 
signalling pathways resulting in different immune-metabolic 
responses (Lachmandas et al. 2016). Furthermore, the origin 
of macrophages for investigation of metabolic signature of 
different macrophage subsets should be considered since it 
could represent essential biochemical information revealing 
key pathways in specific diseases.
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